SOD1 and metabolic dysfunction-associated steatotic liver disease: Our findings demonstrated a significant reduction in MDA, TNF-α, and IL-6 levels, as well as an increase in SOD, GSH, and GHS-Px levels with supplementation of CEL or COT extract in both NAFLD mice and HepG2 cells (Figures 4, 7).